Vivani Medical, Inc, based in Alameda, CA, is a pioneering biopharmaceutical company focused on developing miniaturized long-term implants to improve medication adherence and treatment outcomes for patients with chronic diseases. Their innovative nanoportal implant technology aims to provide steady doses of medication over extended periods, addressing challenges such as medication non-adherence and tolerability.
With a commitment to revolutionizing patient care, Vivani is currently developing lead drug candidates like npm 115 for obesity and npm 119 for type 2 diabetes. Their cutting-edge approach to drug delivery has shown promising preclinical results, positioning them as a key player in the field of long-term biopharmaceutical implants.
Generated from the website